Titomic (ASX:TTT) said its US unit Titomic USA has signed a cooperative research and development agreement (CRADA) with a US military research organization to establish a multi-year framework for collaborative research activities supporting next-generation defense modernization, sustainment, advanced manufacturing, and materials development, according to a Thursday Australian bourse filing.

The company said the agreement establishes a framework for multiple research activities designed to advance the proprietary Titomic Kinetic Fusion (TKF) cold spray technology for military applications that require enhanced survivability, improved readiness, and accelerated manufacturing capability.

Through the CRADA, Titomic and the government organization will jointly investigate advanced TKF applications related to repair, restoration, advanced materials development, survivability enhancement, and expeditionary manufacturing, it added.

The company's shares fell 2% in recent Thursday trade.